| Overview |
| bsm-90004r-50µL |
| Parkinsonism associated deglycase Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human PARK7 |
| 1-66/189 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 11315 |
| Q99497 |
| PARK7; Parkinsonism Associated Deglycase; DJ-1; GATD2; DJ1; Parkinson Disease (Autosomal Recessive Early Onset) 7; Protein/Nucleic Acid Deglycase DJ-1; Parkinson Disease Protein 7; Parkinson Protein 7; Maillard Deglycase; Oncogene DJ1; Protein DJ-1; Epididymis Secretory Sperm Binding Protein Li 67p; Parkinsonism-Associated Deglycase; Protein Deglycase DJ-1; EC 3.5.1.124; EC 3.1.2.-; EC 3.5.1.-; HEL-S-67p |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |